Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Xenetic Biosciences, Inc. (XBIO) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$0.77M |
|
$-0.58M |
|
-- |
|
$0.77M |
|
$1.39M |
|
$-0.62M |
|
$0.04M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.62M |
|
$-0.62M |
|
1.70M |
|
1.70M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$8.05M |
|
-- |
|
$0.31M |
|
$8.36M |
|
$0.97M |
|
-- |
|
-- |
|
$0.97M |
|
$7.39M |
|
$7.40M |
|
$7.40M |
|
2.29M |
|
| Cash Flow Statement Financials | |
$-2.29M |
|
-- |
|
$4.00M |
|
$6.17M |
|
$7.88M |
|
$1.72M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.32 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-81.30% |
|
-81.30% |
|
-- |
|
-75.57% |
|
-75.57% |
|
$-2.29M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-7.83% |
|
-7.83% |
|
-6.92% |
|
-7.83% |
|
$3.23 |
|
$-1.34 |
|
$-1.34 |
|